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Abstract
Mouse models and in vitro cell culture were used to examine airway expression of the mucosal chemokine CCL28. Low levels of constitutively
expressed mRNA were observed in transformed murine epithelial cells, but high levels could be induced by stimulation. Cytokines that signal
through NF-B, including IL-1 and TNF- or via JAK-STAT pathway including oncostatin M induced CCL28 in airway epithelial cells in
vitro. Immunohistochemistry of murine airway tissue revealed that constitutive expression of CCL28 protein in vivo was low and not ubiquitous.
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dowever, abundant expression was detected in epithelia and lymphoid aggregates following allergic sensitization and challenge with ovalbumin.
his was accompanied by increased detection of cells expressing CCR10 protein and mRNA in inflamed airways. Taken together, these data support
role for CCL28 in contributing to allergen driven airway pathologies, show that proinflammatory cytokines can induce this signal and suggest a
ole for CCR10 expressing cells in airway inflammation.
2005 Elsevier B.V. All rights reserved.
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. Introduction
CC chemokine ligand 28 (CCL28) is a CC () chemokine
1,2] encoded on human chromosome 5q (mouse chromosome
3) outside the regular CC chemokine cluster located at human
hromosome 17. It is encoded by four exons, separated by large
ntrons [1,2]. Human and mouse CCL28 are highly conserved
haring 83% amino acid identity and 76% identity at the nucleic
cid level [2]. Despite a putative role in mucosal inflamma-
ion [3–6], there have been few studies of CCL28 expression.
mmunohistochemistry and laser capture microdissection have
ndicated that epithelial cells from colon and salivary tissue
xpressed CCL28 [1] and immuno-electron microscopy showed
CL28 localized to secretory granules within epithelial cells
nd at mucosal sites [3,6]. CCL28 mRNA has been detected
n human trachea and bronchus-associated epithelial cells by
orthern blot analysis [1]. Expression of murine CCL28 is less
ell characterized, but CCL28 has been shown in the testis, and
t lower levels in kidney and brain [2]. These data suggest that
∗
CCL28 has both a homeostatic role and an involvement in the
inflammatory responses of the mucosal immune system [2].
Asthma is a chronic disease of the airways characterized
by inflammation, remodelling and airway hyper-responsiveness
[7]. Epithelial shedding, airway wall thickening, elevated IgE
levels and mucus hyper-secretion are other hallmark features
associated with the disease [7]. Many cell types, including
eosinophils, mast cells and CD4+ T helper type 2 (Th2) lym-
phocytes, play a role in asthmatic airway inflammation [8].
As with most inflammatory conditions, CC chemokines and
pro-inflammatory cytokines have been implicated in the patho-
genesis [9], for example, IL-1 and TNF-, signal via NF-B
activation and are elevated in asthma [10]. Both cytokines are
secreted by activated monocyte/macrophages and have been
characterized as triggers for chemokine expression at sites of
inflammation [11]. Likewise, oncostatin M (OSM), a member
of the IL-6 family can induce CCL11 (eotaxin) linked to air-
way pathology [12]. Until very recently, little was known about
CCL28 induction in humans or in murine models of human dis-
ease [13,14].
The CC chemokine receptors CCR3 and CCR10 are known
to recognize CCL28 [1]. Th2 cells and effector cells such asCorresponding author. Tel.: +353 1 708 3835; fax: +353 1 708 6337.
E-mail address: bpmahon@may.ie (B.P. Mahon). basophils, mast cells and eosinophils express CCR3, and a major
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role for CCL28 in the trafficking of CCR3+ eosinophils has been
proposed [14]. CCR3 engagement is thought to be responsible
for the recruitment of basophils, mast cells and eosinophils to
inflammatory sites, driven by CCL11 (eotaxin) [15,16]. CCL28
can also support chemotaxis of blood eosinophils via this recep-
tor [1]. The pathogenic role of eosinophils in asthma patho-
genesis is not clear but recent work demonstrates a role for
eosinophils in the early events associated with asthma induc-
tion [17,18]. The interaction of CCL28 with CCR3 expressed
by Th2 cells and eosinophils strongly suggests that this novel
chemokine has a role in asthmatic inflammation [6,13], how-
ever, the interaction between CCL28 and CCR10 remains less
explored [2,19].
In the present study, we set out to examine the role of
CCL28 in a murine model of allergic airway inflammation. We
demonstrate that CCL28 is constitutively but not ubiquitously
expressed at low levels by murine airway epithelial cells in vitro
and in vivo. We show that CCL28 expression is upregulated in
vitro by the inflammatory cytokines IL-1 and TNF-, as well
as by OSM. Furthermore, this study demonstrates that whilst
CCL28 is expressed at low levels in healthy airway epithelium,
it is abundantly expressed in the inflamed airways of sensitized
mice and this is associated with an increase of CCR10 expression
at this mucosal site.
2. Materials and methods
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CCL28, CCR3 or CCR10 plasmid DNA. Quantification of target
gene expression was obtained using sequence detector system
software (MJ Research Inc., Waltham, MA).
2.4. Cytokine measurement
Concentrations of IL-4, IL-5, and IL-13 from culture super-
natants were assessed after 24, 48 and 72 h culture by ELISA
(BD Pharmingen, San Diego, CA). Cytokine concentrations
were calculated by comparison with known cytokine standards
as previously described [8], all determinations were made in
triplicate, results are presented as mean cytokine concentration
(±S.E.M.).
2.5. Ova sensitization
Mice were sensitized to OVA or sham sensitized with endo-
toxin free PBS as previously described [8]. Six- to eight-week-
old female BALB/c mice (n = 5 per group minimum, but in
some cases n = 8) (OVA) were sensitized by i.p. injection of
100g Ova (Grade V; Aldrich-Sigma Chemical Co., Dorset,
UK) emulsified in 2% Alhydrogel® adjuvant (Superfos Bio-
sector, Sweden) at 0 and 14 d. Control groups (Ctrl) received
saline alone (i.p.). On day 14, sensitized mice also received
50g Ova or saline intranasally. On 25, 26 and 27 d, sensitized
mice received 50g OVA or saline intra-nasally. On 28 d, mice
were assessed for airway hyper-reactivity by plethysmography,
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i.1. Animals
Six- to eight-week-old female BALB/c (Harlan, UK) mice
ere used for experiments under the guidelines of the Irish
epartment of Health and the research ethics committee of the
ational University of Ireland Maynooth.
.2. Cell lines
Cultured murine lung epithelial cells (MLE-12) were allowed
o adhere to the matrix of the culture plate overnight, before
h stimulation with IL-1, TNF- or OSM (R&D Systems,
bingdon, UK). RNA was then isolated from these cells for use
n RT-PCR.
.3. Quantitative real time RT-PCR
RNA from MLE-12 cells was extracted using Tri ReagentTM
Molecular Research Center, Cincinnati, OH) according to the
anufacturer’s instructions. cDNA was analyzed for the expres-
ion of murine CCL28, CCR3 or CCR10 by fluorogenic 5′-
uclease PCR assay (MJ Research Inc., Waltham, MA). Briefly,
DNA (1.0g) were amplified in the presence of SYBR® Green
CR mastermix, forward and reverse primer sequences were
s previously described [3,6]. As an internal positive control
APDH-specific forward and reverse primers were used in a
imilar reaction. Accumulation of gene-specific PCR products
as measured continuously by means of fluorescence detection
ver 40 cycles. Standard curves for CCL28 expression were gen-
rated amplifying 10-fold serial dilutions of known quantities ofnd then sacrificed. Airway tissue (trachea, bronchi and lungs)
as removed and stored in RNALaterTM (Ambion Inc., Austin,
X) as previously described for detection of CCL28 and CCR10
RNA, or processed for histology and immunohistochemistry.
ll experiments were performed at least twice.
.6. Immunohistochemistry
CCL28-specific reagents were developed from two rab-
its immunized with the following peptide sequence: CGHT-
RKHRTRGTHRHEASR conjugated to BSA. Likewise, CCR-
0-specific reagents were developed from rabbits immu-
ized with the following peptide sequence: RRCRLIF-
ESLTQTVKGC conjugated to BSA. Immunized rabbits were
oosted four times at two weekly intervals. Batches of pre-
nd post-immune sera were tested by dot blot analysis and
LISA (Biosource International, Nivelles, Belgium). Batches
f sera displaying strong specific CCL28 or CCR10 reactivity
ut no binding by irrelevant or related antigens were affinity
urified against the immunogen. Airway tissue was prepared as
reviously described [8]. Tissue was unmasked in tri-sodium
itrate solution (BDH, Cork, Ireland) and blocked with normal
oat serum (Vector Laboratories Ltd., Peterborough, UK). After
vernight incubation with pre-immune or immune sera sections
ere treated with biotin-labelled goat anti-rabbit IgG (Vector
aboratories) and the substrate. Counter-staining was performed
s previously described [8].
.7. Whole-body plethysmography
Airway responsiveness was assessed by methacholine (MCh)
nduced airflow obstruction from conscious mice using whole-
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body plethysmography (Buxco Electronics, Sharon, CT) as
previously described [8]. Pulmonary airflow obstruction was
measured by enhanced pause (PenH), a value determined
from the ratio of expiratory time and relaxation time to
peak expiratory flow and peak inspiratory flow, a surro-
gate of airway responsiveness. Measurements were obtained
after exposure of mice for 3 mins to PBS (baseline) followed
by incremental doses (1.0–50 mg/ml) of MCh delivered by
aerosol.
2.8. Respiratory tract histology
Animals (n between 5 and 8 per group per experiment) were
sacrificed and lungs were removed, fixed in a paraformalde-
hyde/lysine/periodate fixative, paraffin embedded, sectioned and
stained using haematoxylin and eosin, Discombes (identifica-
tion of eosinophils), Alcian blue (identification of mucus), PAS
(assessment of basement membrane thickness) and Van Gieson
(identification of fibrosis) methods as previously described
[8,20,21]. Histopathological changes evident were graded
according to a semi-quantitative scoring system as mild, moder-
ate or severe by two researchers without prior knowledge of the
treatment group using a previously established scoring system.
All experiments were performed at least twice.
2.9. Statistical methods
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Fig. 1. Levels of CCL28 mRNA were determined by quantitative real time PCR
from MLE-12 cells unstimulated or stimulated with varying concentrations of
TNF- (A), IL-1 (B) or OSM (C). Results shown are mean (±S.E.M.) of
three determinations from a representative experiment performed at least three
times; asterisk (*) indicates statistical significance from unstimulated control,
p < 0.005.
or IL-13 at 24 h (Fig. 2A–C) or at 48 h or 72 h culture (data
not shown). Taken together, these results suggest that high level
CCL28 expression by airway epithelial cells can be induced by
direct signalling through transduction pathways usually associ-
ated with microbial insult (IL-1/TNF-, OSM).Results are expressed as the mean ± S.E.M. of the indicated
umber of animals. A Student’s t-test was used to determine sig-
ificance among the groups. A value of p < 0.05 was considered
ignificant. Analyses were performed using Graph-Pad PrismTM
oftware (GraphPad, San Diego, CA).
. Results
.1. CCL28 mRNA is constitutively present in airway
pithelial-like cells but is upregulated by inflammatory
timuli
In order to identify the signals involved in controlling CCL28
xpression, quantitative RT-PCR was performed on cDNA iso-
ated from the airway epithelial-like cell line MLE-12. CCL28
RNA was constitutively expressed at low levels in cultured
LE-12 cells (Fig. 1A–C). However, the expression of many
C chemokines is controlled by cytokines induced by microbial
nsult. The influence of IL-1, TNF- and OSM upon expres-
ion of murine CCL28 mRNA was therefore examined. TNF-
r IL-1 stimulation of MLE-12 cells significantly increased
he mean level of CCL28 mRNA (p < 0.005 and p < 0.005
espectively)(Fig. 1A and B). Cells remained viable through-
ut the period of culture and there was no significant induction
f apoptosis in these experiments. Murine OSM at 1–50 ng/ml
nduced high levels of CCL28 expression in MLE-12 cells
Fig. 1C). Interestingly OSM signals via a type I cytokine recep-
or pathway involving a common gp130 subunit that activates
he JAK-Stat pathway. Stimulation of MLE-12 cells with IL-1,
NF- or OSM did not induce the Th2 cytokines IL-4, IL-5
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Fig. 2. IL-4 (A), IL-5 (B) and IL-13 (C) are not induced from MLE-12 cells.
MLE-12 cells were stimulated with either medium control (open bar), TNF-
 (10 ng/ml), IL-1 (10 ng/ml) or OSM (50 ng/ml) and supernatants assayed at
24 h for the presence of cytokine by commercial ELISA. Recombinant cytokines
(solid) bar are shown for comparison as a positive control. Experiment shown
is representative of two independent studies, assayed in triplicate, presented as
the mean concentration of cytokine detected ±S.E.M.
3.2. Expression of CCL28 protein is limited in the normal
murine airways but is extensive in a murine model of
allergic inflammation
Expression of chemokine mRNA does not always correlate
well with protein production and secretion. Therefore, CCL28
expression in normal healthy murine airways was measured by
immunohistochemistry of fixed tissue. Non-specific labelling
was not observed with control reagents (Fig. 3A and B); however
constitutive CCL28 production could be detected in untreated
control mice or mice exposed to endotoxin-free PBS (Fig. 3C and
D). Expression was not universal but tended to occur in patches
of epithelial cells in the conducting airways (Fig. 3D). In con-
trast to control mice (Fig. 3D), mice that had been sensitized
to OVA mice expressed abundant CCL28 (Fig. 3E–G). CCL28
expression was predominantly within epithelia of the conducting
airways and was associated with the typical eosinophil infiltrate
(Fig. 3E–G, and Table 1) previously reported [8]. Expression
was also detected in lymphoid aggregations associated with
inflammation in OVA sensitized mice (Fig. 3H). Peri-airway
inflammation, assessed in terms of overall degree and absolute
numbers, revealed increased infiltrating eosinophils, neutrophils
and plasma cells in line with our previous observations (Table 1)
as well as an increase in surrogate measures of airway hyper-
reactivity (Fig. 4) [8]. Although the affinity purified reagents
described above showed no non-specific labeling, it was possible
that the CCL28 anti-serum used was detecting an unidenti-
fied chemokine induced under similar conditions. The level of
CCL28 mRNA present in control and OVA sensitized lung tis-
sue was therefore determined by quantitative RT-PCR. Levels
of CCL28 mRNA were significantly greater in sensitized com-
pared to controls (Fig. 5A). Taken together, these data indicate
that CCL28 is present in sensitized airways and suggests that it
plays a role in airway diseases in which eosinophilic infiltrates
are a pathological feature [22].
3
i
s
s
w
s
r
w
(
t
a
s
C
c
P
i
l
s
t
a
4
a
e
c
a.3. CCR10+ cells and levels of CCR10 mRNA are elevated
n inflamed airways
The chemokine receptors CCR3 and CCR10 have been
hown as functional receptors for CCL28 in vitro. CCR3 expres-
ion in OVA sensitized mice has been previously characterized;
e therefore examined CCR10 expression in the airways of mice
ensitized to OVA. Using affinity purified rabbit anti-CCR10
eagents, CCR10 expression could not be detected in the air-
ays of control mice, nor was non-specific labeling detected
Fig. 6), however, as with similar models of CCR3+ infiltra-
ion [23], cells expressing CCR10 were readily detected in the
irway epithelium (Fig. 6F and H) and BALT (Fig. 6D) of OVA-
ensitized mice. However, there was a possibility that rather than
CR10, affinity purified polyclonal reagents were detecting a
losely related ligand. Therefore, CCR10-specific quantitative
CR of cDNA derived from lung tissue was performed. Signif-
cantly more CCR10-specific mRNA could be detected in the
ungs of OVA sensitized mice compared to controls (Fig. 5B),
uggesting that the increased expression seen in OVA sensitized
issue reflects an increased influx of CCR10+ cells (Fig. 6D, F
nd H).
. Discussion
In this study we show that CCL28 is constitutively expressed
t low levels in transformed murine epithelial cells. CCL28
xpression can be upregulated by various proinflammatory
ytokines signalling via both the NF-B (IL-1 and TNF-)
nd JAK-STAT (OSM) pathways [24]. Immunohistochemistry
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Fig. 3. In vivo expression of CCL28 revealed by immunohistochemistry. Mice (n = 8 per group) were either unsensitized (A), sham sensitized with endotoxin-free
PBS (B and D) or sensitized to OVA (E–H). Lung/trachea sections were assayed using an irrelevant polyclonal rabbit serum (A), pre-immune rabbit serum (B)
or a rabbit anti-mouse CCL28 serum (C–H). All sections were probed using biotinylated goat anti-rabbit IgG, streptavidin conjugated horse radish peroxidase
using 3,3′-diaminobenzidine tetrahydrochloride as substrate. All sections were counterstained with haematoxylin. Original magnification ×400. Observations are
representative sections from at least two experiments where n = 5 in each case.
revealed that constitutive expression of CCL28 protein in normal
murine airways was not ubiquitous, but using the OVA model
of airway hyper-reactivity, we demonstrate that CCL28 protein
and mRNA is abundantly expressed in allergen-sensitized air-
ways. Furthermore, we provide evidence that cells expressing
CCR10, a receptor for CCL28, are present in the airways of
OVA sensitized mice.
Cytokines, such as TNF- and IL-1 are known to be
involved in airway inflammation. Both of these cytokines are
elevated in asthma and can signal via activation of NF-B [25].
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Table 1
Pathological score of airway inflammation
Group Hyperplasia of airway epithelium Smooth muscle hypertrophy Peri-airway/vascular inflammationa
Eo PMN L M Overall
Control − − − − − − −
OVA + + + ++ ++ + ++
A semi-quantitative score (− absent, + mild, ++ moderate, +++ severe) was assigned to features of airway pathology observed according to previously described
criteria.
a Peri-airway/vascular inflammation was assessed in terms of overall degree and of numbers of infiltrating eosinophils (Eo), neutrophils (PMN), lymphocytes,
plasma cells and macrophages (L), and the presence of macrophage giant cells (M) in inflammatory exudates within the surrounding alveolar spaces. Results are
representative from histological examination of eight mice (n = 8) scored independently by two observers.
Fig. 4. OVA sensitization induces airway hyper-reactivity in response to increas-
ing concentrations of inhaled methacholine (MCh). Hyper-reactivity was mea-
sured by whole-body plethysmography in unsensitized (control) or sensitized
(OVA) mice. Results are expressed as mean enhanced pause (PenH) ±S.E.M.
from a representative of two experiments (n = 8 mice per group).
IL-1 and TNF- upregulate expression of a range of proin-
flammatory genes that in turn influence aspects of the asthmatic
response such as airway smooth muscle responsiveness [25].
The present findings show for the first time that IL-1 can induce
CCL28 expression by epithelial cells and supports the data of
Ogawa et al who showed TNF- and IL-1 induced CCL28. The
functional activity of the chemokine produced under these con-
ditions will require the development of novel sensitive CCL28
bioassays. The paradox whereby Th1 inducing stimuli including
infection can exacerbate Th2 driven airway pathologies has been
extensively documented [8,20,21,26]. The induction of CCL28
by IL-1 is important because it provides another link through
which pro-inflammatory microbial insult (often considered to
be Th1 driven) can exacerbate asthmatic or allergic responses,
considered as Th2 driven pathologies. One prediction arising out
of this hypothesis is that bacterial inflammation of the airways
would induce IL-1 and a co-ordinated upregulation of CCL28
expression, it would also be predicted that successful respira-
tory pathogens have evolved adversarial strategies to counter
the effects of CCL28. The observation that CCL28 has direct
anti-microbial activity is also consistent with a model in which
airway induction is coupled to the appearance of IL-1 and TNF-
, as early mediators of inflammation [6,27] and suggests that
studies of CCL28 during airway infection would be informative.
We show for the first time that CCL28 can be induced at
high level independently of the NF-B pathway by OSM [24].
OSM is an IL-6 like cytokine that regulates eosinophilic infiltra-
tion in part through CCL11 (eotaxin), induces the proliferation
of smooth muscle cells, and also alters the balance between
matrix metalloproteinases and their tissue inhibitors, again
characteristic of asthma-induced lung pathology [12,28–30].
As both human and mouse OSM are able to upregulate the
expression of MCP-1 by fibroblasts, it has been suggested that
OSM is involved in the pathogenesis of eosinophilic pneumo-
nia, associated with increased levels of MCP-1 in BAL fluid
[12]. Our finding that OSM induces CCL28 from epithelial
cells may mean that some of these effects are mediated in
part through CCL28 and that the epithelium may contribute
t
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Fig. 5. CCL28 and CCR10 mRNA are upregulated in the airways of OVA sensitiz
quantitative real time PCR from lung tissue isolated as descried in Section 2.5. Res
experiment performed at least three times. Statistical significance from unstimulatedo these processes. Although the role of eosinophils in asthma
as attracted some debate, emerging data from murine mod-
ls suggest that eosinophils play a central role in the early
vents of asthma induction including remodelling and hyper-
esponsiveness [13,17,18]. Given that eosinophils express the
CR3 receptor [31], our finding of abundant CCL28 in airway
ed mice. Levels of CCL28, CCR3 and CCR10 mRNA were determined by
ults shown are mean (±S.E.M.) of three determinations from a representative
control, p < 0.005.
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Fig. 6. CCR10 expressing cells can be detected in the airways of OVA sensitized mice. Mice (n = 8 per group) were either sensitized to OVA (A, B, D, F and H) or
sham sensitized with endotoxin-free PBS (C, E and G). Lung sections were assayed using an irrelevant polyclonal rabbit serum (A), pre-immune rabbit serum (B)
or an affinity purified rabbit anti-mouse CCR10 serum (C–H). All sections were probed using biotinylated goat anti-rabbit IgG, streptavidin conjugated horse radish
peroxidase using 3,3′-diaminobenzidine tetrahydrochloride as substrate. Sections were counterstained with haematoxylin. Original magnification ×400 (A–D) or
×800 (E–H).
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epithelium associated with an eosinophil influx indicates that
CCL28 may contribute to eosinophil recruitment to the airway
and in the pathology associated with allergic inflammation.
Recent work by John et al. [14] has demonstrated that
CCL28 is upregulated in another murine model of airway hyper-
responsiveness. Using a different model (OVA) and reagents,
we validate that work and show CCL28 expression in a murine
model of allergic inflammation. However in contrast to that
study, we observed elevated expression of CCR10 protein and
mRNA after allergen challenge of senstitised airways. This
receptor has not previously been implicated in leukocyte hom-
ing in models of airway hyper-responsiveness and its detection
in sensitized airways provides at least circumstantial evidence
consistent with CCL28 playing a role in airway inflammation,
consistent with other studies of CCR10 in vitro or at other
mucosal sites [2,5,19]. However, it would be premature to con-
clude from the approaches in the present study that CCR10 is the
principal receptor involved in this interaction. To date, very lit-
tle data is known about CCR10 and its potential role in mucosal
inflammation [2,5,19], a full understanding of that function in
the airways awaits the development of new reagents and knock-
out mice.
Nevertheless, our findings show that inflammatory media-
tors from different classes can induce CCL28 from airway cells
and that CCL28 is upregulated in a well-characterised model
of airway hyper-responsiveness. We provide the first observa-
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